Literature DB >> 27719638

Targeting Signalling Pathways in Hepatocellular Carcinoma.

Kaja Blagotinsek, Damjana Rozman1.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) represents the most common malignant liver tumor in humans, which incidence and mortality have increased in Europe and United States in the last years. Most patients are diagnosed at an advanced stage, when it is not amenable to curative therapies, so there is an urgent need for new, more effective therapeutic tools and strategies. The molecular mechanisms of hepatocarinogenesis and HCC progression have been increasingly understood with intense research in recent years.
METHODS: The goal of this work is to discuss the different signalling pathways as important potential therapeutic targets.
RESULTS: Disruption of pathways known to play roles in HCC, such as Wnt/β-catenin, Hedgehog, RAF/MEK/ERK, tryosine kinase receptor-related pathway, Met-HGF, VEGF/ VEGF and ROR signalling pathways may be seminal for liver oncogenesis.
CONCLUSION: This review reveals that oncogenes, especially microRNAs that are conserved across species and interfere with signalling pathways might be used as promising strategies for halting or reversing the progression of HCC. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Hepatocellular carcinoma; drug targets; genomics; hepatocarcinogenesis; microRNA; signalling pathway

Mesh:

Substances:

Year:  2017        PMID: 27719638     DOI: 10.2174/1381612822666161006160005

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  12 in total

1.  Sesn3 deficiency promotes carcinogen-induced hepatocellular carcinoma via regulation of the hedgehog pathway.

Authors:  Yunjian Liu; Hyeong Geug Kim; Edward Dong; Chuanpeng Dong; Menghao Huang; Yunlong Liu; Suthat Liangpunsakul; Xiaocheng Charlie Dong
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-07-24       Impact factor: 5.187

Review 2.  The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches.

Authors:  Chi-Tan Hu; Jia-Ru Wu; Chuan-Chu Cheng; Wen-Sheng Wu
Journal:  Cancers (Basel)       Date:  2017-05-26       Impact factor: 6.639

3.  Dandelion Polysaccharide Exerts Anti-Angiogenesis Effect on Hepatocellular Carcinoma by Regulating VEGF/HIF-1α Expression.

Authors:  Feng Ren; Kaixuan Wu; Yun Yang; Yingying Yang; Yuxia Wang; Jian Li
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810

Review 4.  Roles of Nrf2 in Gastric Cancer: Targeting for Therapeutic Strategies.

Authors:  Tahereh Farkhondeh; Ali Mohammad Pourbagher-Shahri; Mohsen Azimi-Nezhad; Fatemeh Forouzanfar; Aranka Brockmueller; Milad Ashrafizadeh; Marjan Talebi; Mehdi Shakibaei; Saeed Samarghandian
Journal:  Molecules       Date:  2021-05-25       Impact factor: 4.411

5.  Tamarix articulata Inhibits Cell Proliferation, Promotes Cell Death Mechanisms and Triggers G0/G1 Cell Cycle Arrest in Hepatocellular Carcinoma Cells.

Authors:  Abdullah M Alnuqaydan; Bilal Rah
Journal:  Food Technol Biotechnol       Date:  2021-06       Impact factor: 3.918

6.  Involvement of P2X7 Receptor in Proliferation and Migration of Human Glioma Cells.

Authors:  Zhenhua Ji; Yuting Xie; Yu Guan; Yujian Zhang; Kin-Sang Cho; Min Ji; Yongping You
Journal:  Biomed Res Int       Date:  2018-01-09       Impact factor: 3.411

7.  MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/β-catenin pathway in hepatocellular carcinoma.

Authors:  Hang Tuo; Yufeng Wang; Liang Wang; Bowen Yao; Qing Li; Cong Wang; Zhikui Liu; Shaoshan Han; Guozhi Yin; Kangsheng Tu; Qingguang Liu
Journal:  Oncotarget       Date:  2017-08-07

Review 8.  Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis.

Authors:  Isabel Fabregat; Daniel Caballero-Díaz
Journal:  Front Oncol       Date:  2018-09-10       Impact factor: 6.244

Review 9.  The Role of Nrf2 Activity in Cancer Development and Progression.

Authors:  Alina-Andreea Zimta; Diana Cenariu; Alexandru Irimie; Lorand Magdo; Seyed Mohammad Nabavi; Atanas G Atanasov; Ioana Berindan-Neagoe
Journal:  Cancers (Basel)       Date:  2019-11-08       Impact factor: 6.639

10.  Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.

Authors:  Han-Zhang Zhu; Wei-Jiang Zhou; Ya-Feng Wan; Ke Ge; Jun Lu; Chang-Ku Jia
Journal:  World J Gastroenterol       Date:  2020-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.